Hi all,
This is another reminder for those who yet has not answered the survey that was circulated earlier (see below).
We have only received response from these five partners:
P3 HMGU Munich
P7 PCB Barcelona
P8 UU Uppsala
P10 RUNMC Nijmegen
P11 LUMC Leiden

Thanks
mathias

On 2012-12-04 17:01, Mathias Brännvall wrote:
Hi all,
I would appreciate if the other partners with sequencing facilities or sequence analysis pipelines could answer the survey before December 19. You could either use the form previously sent or use the attached form where the answers from those who have responded have been included (just make sure you label/mark your answer so we know which one is from you. Questions are in black and answers in any other color) .

Those who already have answered the survey (listed above) can review and revise their answers if necessary.
Best regards
Mathias

  

-------- Original Message --------
Subject: [Geuvadis_rnaseq] Fwd: GEUVADIS QC survey
Date: Tue, 4 Sep 2012 12:13:27 +0200
From: Mathias Brännvall <mathias.brannvall@medsci.uu.se>
To: <geuvadis_exome@lists.crg.es>, <geuvadis_rnaseq@lists.crg.es>


Dear Geuvadis colleagues,
Before the summer vacations started I sent out a survey, see mail below, and so far it is only LUMC (Leiden) who has answered.
I therefor kindly remind the rest of you to please answer it and send to me as soon as conveniently possible.

than you and kind regards
Mathias


-------- Original Message --------
Subject: [Geuvadis_rnaseq] GEUVADIS QC survey
Date: Thu, 31 May 2012 16:59:25 +0200
From: Mathias Brännvall <mathias.brannvall@medsci.uu.se>
To: <geuvadis_exome@lists.crg.es>, <geuvadis_rnaseq@lists.crg.es>


Dear colleagues,
Here at last is the QC-survey for geuvadis. I kindly ask each partner to answer it and send back to me by 11 August at the latest.
As the survey covers both laboratory details and bioinformatics I suggest that each principal investigator at each site delegates the task to the appropriate person(s).

For question 11 and 22: You don't have to describe every data analysis pipeline you have, that would be to much to ask. Please choose one or two you use the most and/or one that you have particular expertise in.

Please don't hesitate to ask me if there is something that is unclear.

Thank you and best summer greetings to all of you.

Mathias


-- 
_____________________________________________
Mathias Brännvall, PhD
Project coordinator
Dept. of Medical Sciences, sect. Molecular Medicine, 
Uppsala University
Akademiska sjukhuset, ing. 70, 3 tr

phone:  +46-(0)18-6114934
mobile: +46-(0)70-1679446

e-mail: Mathias.Brannvall@medsci.uu.se 		







_______________________________________________
Geuvadis_exome mailing list
Geuvadis_exome@lists.crg.es
http://davinci.crg.es/mailman/listinfo/geuvadis_exome






-- 
_____________________________________________
Mathias Brännvall, PhD
Project coordinator
Dept. of Medical Sciences, sect. Molecular Medicine, 
Uppsala University
Akademiska sjukhuset, ing. 70, 3 tr

phone:  +46-(0)18-6114934
mobile: +46-(0)70-1679446

e-mail: Mathias.Brannvall@medsci.uu.se